Su Zhen
Director/Board Member bei KARYOPHARM THERAPEUTICS INC.
Profil
Su Zhen is currently the Chief Executive Officer & Director at Marengo Therapeutics, Inc., an Independent Director at Karyopharm Therapeutics, Inc., and an Independent Director at CytomX Therapeutics, Inc. Previously, Dr. Zhen held the position of SVP & Global Head-Oncology Business at Merck KGaA from 2019 to 2021, and Chief Medical Officer at EMD Serono, Inc. from 2017 to 2019.
Dr. Zhen holds an MBA from the University of Toronto and a doctorate from Dresden University of Technology.
Aktive Positionen von Su Zhen
| Unternehmen | Position | Beginn |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Director/Board Member | 31.08.2023 |
| CYTOMX THERAPEUTICS, INC. | Director/Board Member | 21.03.2024 |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Chief Executive Officer | 01.07.2021 |
Ehemalige bekannte Positionen von Su Zhen
| Unternehmen | Position | Ende |
|---|---|---|
| MERCK KGAA | Chief Tech/Sci/R&D Officer | 01.01.2021 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Chief Tech/Sci/R&D Officer | 01.01.2019 |
Ausbildung von Su Zhen
| University of Toronto | Masters Business Admin |
| Dresden University of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MERCK KGAA | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Health Technology |
